Drug Approval | August 16, 2023
Eugia Pharma receives USFDA Approval for Icatibant Injection
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
The medical device sector is considered as one of the sunrise sectors in the country
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The inspection was conducted at its Goa, Vema manufacturing facility
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Subscribe To Our Newsletter & Stay Updated
